BeCapio
Living Confidently with Fecal Incontinence
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in September 2022 by Gil Senesh, BeCapio operates with 1–10 employees. The company has secured funding across one round from two investors. In November 2022, BeCapio received seed funding from The Trendlines Group and Israel Innovation Authority.
Business overview
BeCapio is a Health Tech & Life Sciences company focused on developing solutions for individuals dealing with Fecal Incontinence Disorder. The company provides a discrete, non-invasive, multi-modal therapy designed to help patients regain control and maintain everyday activities. BeCapio operates within the Digital Healthcare and Digital Therapeutics sectors, targeting patients in the healthcare market with a B2C business model.
Company Intelligence Q&A
- When was BeCapio founded?
- BeCapio was founded in September 2022.
- Who is the founder of BeCapio?
- Gil Senesh is the Co-founder and CEO of BeCapio.
- What is BeCapio's primary focus?
- BeCapio aims to help individuals with Fecal Incontinence Disorder by providing a discrete, non-invasive, multi-modal therapy to regain control and maintain daily activities.
- Which sector does BeCapio primarily operate in?
- BeCapio primarily operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Digital Therapeutics.
- Has BeCapio received any funding?
- In November 2022, BeCapio received seed funding from The Trendlines Group and Israel Innovation Authority.